Analyst Recommendations
56.88 -0.07(-0.12%)07/08/2024
RxSight Inc (RXST)
RxSight Inc (RXST)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 8 |
Outperform | 5 |
Overweight | 2 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades